Company intelligence / Profile preview

Blue Ocean Biomedical

Pembroke Pines, Florida, USAlinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Prior to its acquisition by Beckman Coulter Life Sciences in 2012, Blue Ocean Biomedical developed and commercialized fully integrated automated flow cytometry systems that simplified sample preparation and analysis workflows. Their SIRO approach represented a significant innovation for routine clinical analysis. Products were distributed primarily within the European Union at the time of acquisition.

Industry: Protein Biomarker Diagnostics

Partnerships

Technology incorporated into Beckman Coulter’s product lines.

Beyond the preview

Go deeper on Blue Ocean Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Ocean Biomedical.

Explore the full profile